Futurebrainsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-06-02
Share capital
50,000.00 PLN
Activity description

Futurebrain is a research and development venture focused on neuropsychiatry and neuroimmunology, aiming to revolutionize the treatment and care of neuropsychiatric disorders. The company plans to launch a commercial venture that will offer solutions and products developed through their research, including artificial intelligence and digital health solutions for fast and low-cost diagnosis and treatment. Additionally, they operate their own medical clinic to facilitate these services.

Registered address
ul. Gen. Jarosława Dąbrowskiego 15 A, 64-100 Leszno, Poland
Website
futurebrain.pl
Email
Phone
Electronic delivery address
AE:PL-43871-89908-JRBJU-27

Financials

Revenue history

Filing timeliness

Financial statements were filed on time, on average 59 days early.

  • 202514/05/2026
  • 202429/04/2025
  • 202306/06/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

News

FutureBrain: busy months of meetings and conferences

FutureBrain: busy months of meetings and conferences

February and March this year were very busy months for FutureBrain. Meetings, conferences in different parts of the world, and among them a visit to the leader of world medicine, the Mayo Clinic, U.S. These meetings only confirmed our belief that FutureBrain is becoming a leader among other medical startups, which we are very happy about. And this is just the beginning…

Industry

Offer

  • Scientific research
  • Research and development
  • Neuropsychiatric research
  • Digital health solutions
  • Neuropsychiatric diagnostics

Website technology

Website
  • WordPress

Authorized Representatives

Marcin Jacek Narloch – Management Board Member
Paweł Piotr Wańkowicz – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Marcin Jacek Narlochage 48
500$6,753.1150%
Paweł Piotr Wańkowiczage 43
500$6,753.1150%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Scope FluidicsS.A.
FamicordtxS.A.
Saventic Healthsp. z o.o.
Medrisesp. z o.o.
Medicofarma BiotechS.A.
New Valuesp. z o.o.
Braintechsp. z o.o.
Microbiota Medsp. z o.o.
Passio Human Microbiomesp. z o.o.
Iqcredosp. z o.o.

FAQ

Last updated: 2026-05-14